Health committee  I think I would say that the issue is situation-specific, product-specific, and context-specific. Purchasing in the context of transplantation tourism is what I was responding to, but in the broader context, I think the ethical underpinnings of different scenarios would need to b

Health committee  I don't know. I haven't conceptualized it, but the context in which the question was asked, or at least that I was responding to, was tourism.

Health committee  Thank you. In a former life I spent a lot of time thinking about prevention at the end of the spectrum that you're referring to. I'm grateful for the question. The classical remediable, preventable causes of chronic disease come to mind right away. We know them to be alcohol, t

Health committee  Just like our colleagues, we support a transactional touchpoint that will raise awareness, especially if it leads to the conversation. I think the comments my colleague from Ontario made with respect to being sensitive to the provincial systems this will feed into is an important

Health committee  Thank you very much. I'm sorry, but I'm going to continue in English. Thank you.

Health committee  Yes, it would take time. First, thank you very much. I do not believe that we're close to the maximum. I think there is a strong opportunity for improvement. I think the kinds of things that we've heard, particularly from our provincial program colleagues today, give us a very g

Health committee  We haven't done a legal analysis of the implications, but from an ethical point of view we clearly abhor that behaviour and would support in principle strongly conveying that piece.

Health committee  Absolutely.

Health committee  Thank you. I'll start. To be specific, Health Canada helps our work at Canadian Blood Services to the tune of $3.58 million a year. It's not insignificant at all. It's a tremendous support to us. That resource supports a number of different activities. A lot of the work that we d

Health committee  We sort of run the in middle of the pack when you look at national comparatives that are similar to us. We've heard the example of Spain, which for deceased donation is about double our rate. However, we're doing reasonably well, certainly when you look at improvements over time

Health committee  Thank you very much for the introduction. I'm Isra Levy. I'm the vice-president of medical affairs and innovation at Canadian Blood Services, and there I work with our organ and tissue donation and transplantation team, supporting and coordinating Canada's provincial and territ